id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-1260-0008,FDA,FDA-2015-N-1260,Fixed-Combination and Co-Packaged Drugs: Applications for Approval and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter Monograph Proposed Rule; Reopening of the Comment Period,Proposed Rule,Reopening of Comment Period,2016-04-18T04:00:00Z,2016,4,2016-04-18T04:00:00Z,2016-05-19T03:59:59Z,2016-05-18T22:00:30Z,2016-08888,0,0,0900006481f70598
FDA-2015-N-1260-0006,FDA,FDA-2015-N-1260,Request for Extension from BASF Corporation (Morgan Lewis),Other,Request for Extension,2016-03-22T04:00:00Z,2016,3,2016-03-22T04:00:00Z,,2016-03-22T13:41:13Z,,0,0,0900006481ed33a5